Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)

NCT07149428 is registered in ClinicalTrials.gov with National Institute on Deafness and Other Communication Disorders (NIDCD) as lead sponsor.

NCT NCT07149428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07149428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)
Lead sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Phase
Observational
Overall status
Recruiting
Start date
October 1, 2026
Completion date
October 14, 2030
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anosmia, covid-19, depression, hyposomia, influenza, normosomia, parosmia, respiratory tract infection, rhinosinusitis, smell disorder